Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Jun 19, 2019, 15:35 ET Quadrant Biosciences Takes Next Step in the Detection of Autism

Quadrant Biosciences Inc., a developer of epigenetic diagnostic technologies, has been awarded a $330,000 grant from the National Institutes of...


Jun 19, 2019, 14:05 ET El primer brazo robótico exitoso de la historia controlado por la mente sin implantes cerebrales

Un equipo de investigadores de la Universidad Carnegie Mellon, en colaboración con la Universidad de Minnesota, ha dado un gran paso de avance en el...


Jun 19, 2019, 14:05 ET Primer brazo robótico controlado por la mente que funciona sin implantes cerebrales

Un equipo de investigadores de la Universidad Carnegie Mellon, en colaboración con la Universidad de Minnesota, hizo un hallazgo revolucionario en el ...


Jun 19, 2019, 14:05 ET Tout premier bras robotique contrôlé par l'esprit sans implants cérébraux

Une équipe de chercheurs de l'Université Carnegie Mellon, en collaboration avec l'Université du Minnesota, a fait une découverte capitale dans le...


Jun 19, 2019, 14:05 ET Primeiro bem-sucedido braço robótico controlado pela mente sem implantes no cérebro

Uma equipe de pesquisadores da Universidade Carnegie Mellon, em colaboração com a Universidade de Minnesota, fez um grande progresso no campo do...


Jun 19, 2019, 14:05 ET Erster erfolgreich durch Gedanken gesteuerter Roboterarm - ohne Gehirnimplantate

Einem Forscherteam der Carnegie Mellon-Universität gelang in Zusammenarbeit mit der Universität von Minnesota ein Durchbruch im Bereich der...


Jun 19, 2019, 14:05 ET First-ever successful mind-controlled robotic arm without brain implants

A team of researchers from Carnegie Mellon University, in collaboration with the University of Minnesota, has made a breakthrough in the field of...


Jun 19, 2019, 12:48 ET Portola Presents New Interim Data on its Oral SYK/JAK Inhibitor Cerdulatinib in Heavily Pre-Treated Patients with Relapsed/Refractory Follicular Lymphoma

Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced new interim results from the Company's ongoing Phase 2a study of cerdulatinib, an...


Jun 19, 2019, 10:30 ET Bayer's Stivarga® (regorafenib) becomes first compound used in clinical trial platform to investigate new therapies for brain cancer

Bayer announced today that the Stivarga® (regorafenib) arm of the platform trial GBM AGILE (Glioblastoma Adaptive Global Innovative Learning...


Jun 19, 2019, 09:00 ET New Studies Suggest That DiA's AI-based Software, LVivo EF, Is Accurate and Efficient in Assessing Ejection Fraction Values Compared to Cardiac MRI and Contrast Echocardiography

DiA Imaging Analysis, the developers of artificial intelligence (AI) powered ultrasound analysis solutions, has announced today the presentation of...


Jun 19, 2019, 08:47 ET New globally developed, science-based guidelines on optimal use of denture adhesives for patients' wellbeing and overall health

New global guidelines have been announced to tackle the lack of advice in the best use of denture adhesives with complete edentulous patients....


Jun 19, 2019, 08:30 ET Sophiris Bio Receives Positive Feedback from European Medicines Agency Regarding Phase 3 Localized Prostate Cancer Clinical Trial Design

Sophiris Bio Inc. (NASDAQ: SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class,...


Jun 19, 2019, 07:00 ET Intec Pharma Announces Results From Pharmacokinetic Study of AP-CD/LD 50/500 mg Dosed Three Times Daily Were Presented at the XXIV World Congress on Parkinson's Disease and Related Disorders

Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announced that results from a pharmacokinetics (PK) study of the Accordion...


Jun 19, 2019, 07:00 ET High Point Clinical Trials Center Joins ProSciento's NASH PASS™ Initiative Focused on Accelerating NAFLD/NASH Clinical Trial Recruitment

High Point Clinical Trials Center, LLC, the largest independent clinical research unit in North Carolina, announced today a three-year collaboration...


Jun 19, 2019, 07:00 ET Scientists Identify Genes Associated with Biliary Atresia Survival

Scientists at Cincinnati Children's Hospital Medical Center have identified an expression pattern of 14 genes at the time of diagnosis that predicts...


Jun 18, 2019, 18:09 ET MYOS RENS' Fortetropin® Shown to Increase the Rate of Muscle Protein Synthesis in Older Adults in Clinical Study Carried out at University of California, Berkeley

MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary...


Jun 18, 2019, 17:00 ET Medimetriks Pharmaceuticals Focuses on Advancing MM36 (difamilast) Through Phase 3 Trials; Extinguishes Debt Owed to Knight Therapeutics

Medimetriks Pharmaceuticals, Inc. today announced that the Company is in discussions for various financing options to advance MM36 (difamilast)...


Jun 18, 2019, 16:00 ET Denovo Biopharma Receives Global Rights to a Novel Late-Stage Drug for Alzheimer's Disease from Orion Corporation for Development as a Personalized Medicine

Denovo Biopharma LLC, a pioneer in applying precision medicine to develop innovative therapies, today announced it has licensed ORM-12741 from Orion...


Jun 18, 2019, 12:50 ET Emmaus Life Sciences' 'Sideline Sickle Cell' Campaign Teams Up with SCTPN for World Sickle Cell Day Event on June 19

Emmaus Life Sciences, Inc. ("Emmaus"), a leader in sickle cell disease (SCD) treatment, announced today that the company's Sideline Sickle Cell...


Jun 18, 2019, 10:24 ET Alligator Bioscience Submits Clinical Trial Application for ATOR-1017

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy,...


Jun 18, 2019, 09:30 ET Mill Creek Life Sciences Receives Grant from Regenerative Medicine Minnesota for Development of Dendritic Cell Vaccine

Mill Creek Life Sciences, LLC (Mill Creek), a Rochester, MN based start-up that supports the development and application of cellular and biological...


Jun 18, 2019, 09:30 ET Therapix Biosciences Announces Interim Results of Phase IIa Study at Assuta Medical Center for Obstructive Sleep Apnea Program

TEL AVIV, Israel, June 18, 2019 /PRNewswire/ - Therapix Biosciences Ltd. ("Therapix" or "the Company") (Nasdaq: TRPX), a specialty, clinical-stage...


Jun 18, 2019, 09:18 ET PreludeDx Presents New Research in Luminal Stage 1 Breast Cancer Patients at the 2019 American Society of Clinical Oncology Annual Meeting

Prelude Corporation (PreludeDx), a leader in molecular diagnostics and personalized medicine for early stage breast cancer, announced today its...


Jun 18, 2019, 09:00 ET Theravance Biopharma Reports New Data from Phase 2 Study of Ampreloxetine (TD-9855) in Presentation at 2019 International Association of Parkinsonism and Related Disorders (IAPRD) World Congress

Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today reported new data from the Company's Phase 2 clinical trial ...


Jun 18, 2019, 08:40 ET Oramed Provides Clinical Update with Meaningful Data Expected by Year-End

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery...